| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.04 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |